SA
Log In
BNTX
OverviewIntelligenceChart
Earnings in 5 days · May 5, 2026 · Before open
Signal
Bullish Setup2↑
Price
1↑
Move↑+1.85%Positive session
Volume
1→
Volume→0.6× avgNormal activity
Technical
1↑
RSI↑RSI 68Momentum positive
PRICE
Prev Close
101.57
Open
102.30
Day Range102.30 – 104.81
102.30
104.81
52W Range79.52 – 124.00
79.52
124.00
54% of range
VOLUME & SIZE
Avg Volume
1.1M
FUNDAMENTALS
P/E Ratio
-18.8x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.13
Market-like
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +4% YoY · 78% gross margin
Valuation
FAIR
P/E not available
Health
MODERATE
CR 7.5 · FCF negative
Bullish
Key MetricsTTM
Market Cap$22.28B
Revenue TTM$2.86B
Net Income TTM-$1.13B
Free Cash Flow$276.65M
Gross Margin77.7%
Net Margin-39.6%
Operating Margin-45.9%
Return on Equity-6.0%
Return on Assets-5.2%
Debt / Equity0.01
Current Ratio7.54
EPS TTM$-4.62
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong3 concern
50/100
Liquidity
7.54Strong
Leverage
0.01Strong
Coverage
-29.7xConcern
ROE
-6.0%Concern
ROIC
-6.6%Concern
Cash
$7.7BStrong
ANALYST COVERAGE24 analysts
BUY
▲ +34.4%upside to target
L $113.00
Med $139.00consensus
H $155.00
Buy
2083%
Hold
417%
20 Buy (83%)4 Hold (17%)0 Sell (0%)
Full report →
Stock Health
Composite Score
3 of 4 signals bullish
8/10
Technicals
●
RSI RangeRSI 68 — Bullish momentum
✓
Fundamentals
●
Last EarningsMissed estimates
✗
●
Analyst ConsensusBuy
✓
●
LiquidityCurrent Ratio 7.54 — healthy liquidity
✓

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings Report · Before OpenMay 1, 2026
Tomorrow
DEx-Dividend DateJul 29, 2026
In 90 days
PDividend PaymentJul 31, 2026
In 92 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBULLISH
Technicals →

Trend

▲ RallyDeath Cross · 50D trails 200D by 0.7%

+0.5% vs SMA 50 · -0.2% vs SMA 200

Momentum

RSI68.3
Positive momentum, not extended
MACD-4.51
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$124.0+19.9%
Current
$103.5
EMA 200
$102.4-1.0%
EMA 50
$97.83-5.4%
52W Low
$79.52-23.1%
52-Week RangeMid-range
$79.5254th %ile$124.0
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 13 analysts
Full estimates →
Analyst revisions:EPS↑ Revised UpRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$2.7B
$2.6B–$2.9B
—-$3.51—
±17%
High13
FY2026(current)
$2.3B
$2.1B–$2.4B
▼ -16.4%-$4.31—
±36%
High13
FY2027
$2.4B
$1.6B–$3.3B
▲ +3.4%-$4.55—
±50%
High12
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryBNTX
Last 8Q
+37.8%avg beat
Beat 5 of 8 quartersMissed 3↓ Estimates falling
-6%
Q2'24
-65%
Q3'24
+151%
Q4'24
+149%
Q1'25
+27%
Q2'25
+32%
Q3'25
+87%
Q4'25
-73%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
Goldman SachsNeutral → Buy
Jan 16
UPGRADE
Evercore ISIOutperform
Nov 19
UPGRADE
Goldman SachsBuy
Nov 8
UPGRADE
Morgan StanleyEqual-Weight → Overweight
Sep 23
UPGRADE
Deutsche BankBuy
Aug 6
UPGRADE
J.P. MorganUnderweight
Dec 1
DOWNGRADE
CitigroupUnderweight
Dec 1
DOWNGRADE
Redburn PartnersBuy
May 17
UPGRADE
Bank of America Sec…Buy
Dec 15
UPGRADE
Insider Activity
SEC Filings →
0 Buys/1 SellNet Selling
NET SELLERS$0 bought · $5.5M sold · 30d window
Poetting SierkCOO
$5.5M
Apr 22
SELL
Financials

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
FLOSSBACH VON STORCH AG
3.7M▼
2
La Banque Postale Asset Management SA
385K▲
3
SG Americas Securities, LLC
270K▼
4
Pictet Asset Management Holding SA
132K▲
5
Slow Capital, Inc.
48K▲
6
Swedbank AB
46K▼
7
Raiffeisen Bank International AG
35K▲
8
USS Investment Management Ltd
33K▲
News & Activity

BNTX News

20 articles · 4h ago

About

everyone achieves greatness at biontech! as one of the most rapidly growing biotechnology companies in europe, we’re working on revolutionary approaches in the fight against cancer and other diseases. over 400 dedicated, passionate pioneers achieve sensational success and promising breakthroughs time and again by forging new paths – and ensure people all around the world have hope for the future. you too can become a pioneer! http://biontech.de/ http://biontech.de/imprint/

Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Ugur Sahin
Country
Germany
Website
biontech.de ↗
Oliver HenningSenior Vice President of Operations
Sebastian KreiterSenior Vice President of Immunotherapy & Preclinical Research
Jasmina AlatovicVice President Corporate Communications

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance